A Phase 1b First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia.
Jeffrey CrawfordRoberto A CalleSusie M CollinsYan WengShannon L LubaczewskiClare BuckeridgeEllen Q WangMagdalena A HarringtonAnil TarachandaniMichelle I RossulekJames H RevkinPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
gov: NCT04299048.